Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty

Circulation

Volumn 96, Issue 8, 1997, Pages 2551-2556

  Barsness, Gregory W ^a,b   Peterson, Eric D ^a   Ohman, E Magnus ^a   Nelson, Charlotte L ^a   DeLong, Elizabeth R ^a   Reves, Joseph G ^a   Smith, Peter K ^a   Anderson, R David ^a   Jones, Robert H ^a   Mark, Daniel B ^a   Califf, Robert M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Angioplasty; Bypass; Diabetes mellitus; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIABETIC ANGIOPATHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0030764415     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.8.2551     Document Type: Article

References (53)

1. Ellis SG, Vandormael MG, Cowley MJ, DiSciascio G, Deligonul U, Topol EJ, Bulle TM, the Multivessel Angioplasty Prognosis Study Group. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease: implications for patient selection. Circulation. 1990;82:1193-1202.
2. Weintraub WS, Kosinski AS, Brown CL, King SB III. Can restenosis after coronary angioplasty be predicted from clinical variables? J Am Coll Cardiol. 1993;21:6-14.
3. Levine GN, Leya F, Keeler GP, Berdan LG, Jacobs AK, the CAVEAT Investigators. The impact of diabetes mellitus on restenosis after directional coronary atherectomy and PTCA: a report from CAVEAT I. Circulation. 1994;90(suppl I):I-652. Abstract.
4. Mueller HS, Lawrence SC, Braunwald E, Forman S, Feit F, Ross A, Schweiger M, Cabin H, Davison R, Miller D, Solomon R, Knatterud GL. Predictors of early morbidity and mortality after thrombolytic therapy of acute myocardial infarction. Circulation. 1992;85:1254-1264.
5. Alderman EL, Corley SD, Fisher LD, Chaitman BR, Faxon DP, Foster ED, Killip T, Sosa JA, Bourassa MG. Five-year angiographic follow-up of factors associated with progression of coronary artery disease in the Coronary Artery Surgery Study (CASS). J Am Coll Cardiol. 1993;22:1141-1154.
6. Gadaleta D, Risucci DA, Nelson RL, Tortolani AJ, Hall M, Parnell V, Chiodo C, Green S. Effects of morbid obesity and diabetes mellitus on risk of coronary artery bypass grafting. Am J Cardiol. 1992;70:1613-1614.
7. Wells S. Postoperative recovery: how diabetes complicates care. J Cardiovasc Nurs. 1993;7:47-58.
8. Yamazaki K. Kato H, Tsujimoto S. Kitamura R. Diabetes mellitus, internal thoracic artery grafting, and risk of an elevated hemidiaphragm after coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 1994;8:437-440.
9. Slaughter MS. Olson MM, Lee JT Jr. Ward HB. A fifteen-year wound surveillance study after coronary artery bypass. Ann Thorac Surg. 1993;56:1063-1068.
10. Weintraub WS, Stein B, Gebhart SP, Craver JM, Jones EL, Guyton RA. The impact of diabetes on the initial and long-term outcome of coronary artery bypass surgery. Circulation. 1995;92(suppl I):I-643. Abstract.
11. Smith LR, Harrell FE Jr, Rankin JS, Califf RM, Pryor DB, Muhlbaier LH, Lee KL, Mark DB, Jones RH. Oldham HN, Glower DD. Reves JG, Sabiston DC Jr. Determinants of early versus late cardiac death in patients undergoing coronary artery bypass graft surgery. Circulation. 1991;84(suppl III):III-245-III-253.
12. James TW, Quinton HB, Birkmeyer JD, Dacey LJ, Hernandez F, Leavitt BJ, Maloney CT, Morton JR, Adrian L, O'Connor GT. Diabetes and coronary artery bypass graft surgery risk. Circulation. 1996;94(suppl I):I-412. Abstract.
13. Fietsam RJ, Bassett J, Glover JL. Complications of coronary artery surgery in diabetic patients. Am Surg. 1996;57:551-557.
14. Pocock SJ, Henderson RA, Rickards AF, Hampton JR. King III SB, Hamm CW. Puel J, Hueb W, Goy J-J. Rodriguez A. Metaanalysis of randomised trials comparing coronary angioplasty with bypass surgery. Lancet. 1995;346:1184-1189.
15. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 1996;335:217-225.
16. Ferguson JJ. NHLBI BARI clinical alert on diabetics treated with angioplasty. Circulation. 1995;92:3371.
17. Weintraub WS, Mauldin PD, Becker E, Kosinski AS, King SB III. A comparison of the costs of and quality of life after coronary angioplasty or coronary surgery for multivessel coronary artery disease: results from the Emory Angioplasty Versus Surgery Trial (EAST). Circulation. 1995;92:2831-2840.
18. Bertrand M. Long-term follow-up of European revascularization trials. Presented at the 68th Scientific Sessions of the American Heart Association, Plenary Session XII, Anaheim, Calif, November 16, 1995.
19. Weintraub WS, King SB III, Guyton RA, Kosinski AS. Coronary surgery and PTCA in diabetics with multivessel disease: can the BARI results be generalized? Circulation. 1996;94(suppl I):I-435. Abstract.
20. Gum PA, McGraw J, O'Keefe JH Jr, Borkon AM, Bateman TM, McCallister BD. Is bypass surgery superior to coronary angioplasty for revascularization of diabetic patients? Circulation. 1996; 94(suppl I):I-537. Abstract.
21. Mark DB, Nelson CL, Califf RM, Harrell FE Jr, Lee KL, Jones RH, Fortin DF, Stack RS, Glower DD, Smith LR, DeLong ER, Smith PK, Reves JG, Jollis JG, Tcheng JE, Muhlbaier LH, Lowe JE, Phillips HR III, Pryor DB. Continuing evolution of therapy for coronary artery disease: initial results from the era of coronary angioplasty. Circulation. 1994;89:2015-2025.
22. Jones RH, Kesler K, Phillips HR 3d, Mark DB, Smith PK, Nelson CL, Newman MF, Reves JG, Anderson RW, Califf RM. Long-term survival benefits of coronary artery bypass grafting and percutaneous transluminal angioplasty in patients with coronary artery disease. J Thorac Cardiovasc Surg. 1996;111:1013-1025.
23. Califf RM, Harrell FE Jr, Lee KL, Rankin JS, Hlatky MA, Mark DB, Jones RH, Muhlbaier LH, Oldham HN Jr, Pryor DB. The evolution of medical and surgical therapy for coronary artery disease: a 15-year perspective. JAMA. 1989;261:2077-2086.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. JAm Stat Assoc. 1958;53:457-481.
25. Charlson ME, Pompei P, Ales KL, Mackenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40:373-383.
26. BARI Investigators. The influence of diabetes on five year mortality and morbidity after angioplasty (PTCA) and bypass surgery (CABG) in the BARI randomized trial. Circulation. 1996;94(suppl I):I-318. Abstract.
27. CABRI Trial Participants. First-year results of CABRI (Coronary Angioplasty versus Bypass Revascularisation Investigation). Lancet. 1995;346:1179-1184.
28. Hamm CW, Reimers J, Ischinger T, Rupprecht HJ, Berger J, Bleifeld W. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. N Engl J Med. 1994;331:1037-1043.
29. King SB, 3rd, Lembo NJ, Weintraub WS, Kosinski AS, Barnhart HX, Kutner MH, Alazraki NP, Guyton RA, Zhao XQ. A randomized trial comparing coronary angioplasty with coronary bypass surgery: Emory Angioplasty versus Surgery Trial (EAST). N Engl J Med. 1994;331:1044-1050.
30. RITA Trial Participants. Coronary angioplasty versus coronary artery bypass surgery: the Randomized Intervention Treatment of Angina (RITA) trial. Lancet. 1993;341:573-580.
31. Nathan DM. Long-term complications of diabetes mellitus. N Engl J Med. 1993;328:1676-1685.
32. Barbash GI, White HD, Modan M, Van de Werf F. Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy: investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial. J Am Coll Cardiol. 1993;22:707-713.
33. Orlander PR, Goff DC. Morrissey M, Ramsey DJ, Wear ML, Labarthe DR, Nichaman MZ. The relation of diabetes to the severity of acute myocardial infarction and post-myocardial infarction survival in Mexican-Americans and non-Hispanic whites: the Corpus Christi Heart Project. Diabetes. 1994;43:897-902.
34. Jelesoff NE, Feinglos M, Granger CB, Califf RM. Outcomes of diabetic patients follows acute myocardial infarction: a review of the major thrombolytic trials. Coron Artery Dis. 1996;7:732-743.
35. Jacoby RM, Nesto RW. Acute myocardial infarction in the diabetic patient: pathophysiology, clinical course and prognosis. J Am Coll Cardiol. 1992;20:736-744.
36. Rabbani LE, Edelman ER, Ganz P, Selwyn AP, Loscalzo J, Bittl JA. Relation of restenosis after excimer laser angioplasty to fasting insulin levels. Am J Cardiol. 1994;73:323-327.
37. Frid DJ, Fortin DF, Gardner LH, Nelson CL, Smith JE. Navetta FI, Rendall DS, Ramos R, Harlan WR, Tcheng JE, O'Connor CM, Wall TC, Stack RS, Califf RM. The effect of diabetes on restenosis. J Am Coll Cardiol. 1991;17:268A. Abstract.
38. Hassinger NL, Grill DE, Holmes DR Jr. Outcomes and their predictors after PTCA in patients with type II diabetes mellitus. Circulation. 1996;94(suppl I):I-436. Abstract.
39. Holmes DR, Detre K, Weh WL, King SB, Kelsey S. Eight year, long term outcome after PTCA: factors associated with adverse events: the NHLBI PTCA registry. J Am Coll Cardiol. 1996;27:361A. Abstract.
40. Faxon DP, Kip KE, Currier JW, Yeh W, Detre K. Diabetics have a significantly poorer 8-year outcome after angioplasty. Circulation. 1995:92(suppl I):I-76. Abstract.
41. Stein B, Weintraub WS, Gebhart SP, Cohen-Bernstein CL, Grosswald R, Liberman HA, Douglas JS Jr, Morris DC, King SB III. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. Circulation. 1995;91:979-989.
42. Vandormael M, Deligonul U, Taussig S, Kern MJ. Predictors of long-term cardiac survival in patients with multivessel coronary artery disease undergoing percutaneous transluminal coronary angioplasty. Am J Cardiol. 1991;67:1-6.
43. Bach R, Jung F, Kohsiek I, Ozbek C, Spitzer S, Scheller B, Dyckmans J, Schieffer H. Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty. Thromb Res. 1994;74:S55-S67.
44. Kip KE, Faxon DP, Detre KM, Yeh W, Kelsey CF, Currier JW, for the Investigators of the NHLBI PTCA Registry. Coronary angioplasty in diabetic patients: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. Circulation. 1996;94:1818-1825.
45. Simpfendorfer C. Efficacy of beta blockade, thrombolytic therapy, and coronary angioplasty in diabetic patients with coronary artery disease. Cleve Clin J Med. 1993;60:145-149.
46. Ward SR, Lincoff AM, Miller DP, Booth JE, Montague EA, Tcheng JE, Topol EJ. Clinical outcome is improved at 30 days regardless of pre-treatment clinical and angiographic risk in patients receiving abciximab for angioplasty: results from the EPILOG study. Circulation. 1996;94(suppl I):I-198. Abstract.
47. Carrozza JP Jr, Kuntz RE, Fishman RF, Baim DS. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus. Ann Intern Med. 1993;118:344-349.
48. Hendra TJ, Yudkin JS. An algorithm for tight glycaemic control in diabetic infarct survivors. Diabetes Res Clin Pract. 1992;16:213-220.
49. Opie LH. Glucose and the metabolism of ischaemic myocardium. Lancet. 1995;345:1520-1521.
50. Schaff HV, Rosen AD, Shemin RJ, Leclerc Y, Wareing TH, Aguirre FV, Sopko G, VanderSalm TJ, Loop FD, and the BARI Investigators. Clinical and operative characteristics of patients randomized to coronary artery bypass surgery in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1995;75:18C-26C.
51. Williams DO, Baim DS, Bates E, Bonan R, Bost JE, Cowley M, Faxon DP, Feit F, Jones R, Kellett MA Jr, Kelsey SF, Sopko G, Stadius M, Topol EJ, and the BARI Investigators. Coronary anatomic and procedural characteristics of patients randomized to coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). Am J Cardiol. 1995;75:27C-33C.
52. Morris JJ, Smith LR, Jones RH, Glower DD, Morris PB, Muhlbaier LH, Reves JG, Rankin JS. Influence of diabetes and mammary artery grafting on survival after coronary bypass. Circulation. 1996; 84(suppl III):III-275-III-284.
53. Muhlbaier LH, Pryor DB, Rankin JS, Smith LR, Mark DB, Jones RH, Glower DD, Harrell FE Jr, Lee KL, Califf RM, Sabiston DC. Observational comparison of event-free survival with medical and surgical therapy in patients with coronary artery disease. Circulation. 1992;86(suppl II):II-198-II-204.